Milestone Scientific to Announce 2007 Second Quarter Results on Wednesday, August 15, 2007
August 06 2007 - 9:30AM
PR Newswire (US)
Management to Host Teleconference Same Afternoon at 4:15 PM ET
LIVINGSTON, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Milestone
Scientific, Inc. (OTC:MLSS) (BULLETIN BOARD: MLSS) , the recognized
leader in advanced injection technologies, today reported that it
will announce its 2007 second quarter financial and operational
results on Wednesday, August 15, 2007. The Company will host a
teleconference the same afternoon beginning at 4:15 PM Eastern
Time, and invites all interested parties to join management in a
discussion regarding the Company's financial performance, corporate
progression and other meaningful developments. The conference call
can be accessed by dialing toll-free 1-800-219-6110. For those
unable to participate at that time, a replay of the teleconference
can be accessed domestically by dialing 1-800-405-2236 and enter
the passcode 11094938#. The replay will be available for 90 days.
About Milestone Scientific, Inc. Headquartered in Livingston, New
Jersey, Milestone Scientific is engaged in pioneering proprietary,
highly innovative technological solutions for the medical and
dental markets. Central to the Company's IP platform and product
development strategy is its patented CompuFlo(TM) technology for
the improved and painless delivery of local anesthetic.
Specifically, CompuFlo is a computer-controlled, pressure sensitive
infusion, perfusion, suffusion and aspiration technology, which
provides real-time readouts of pressures, fluid densities and flow
rates, enabling the advanced delivery and removal of a wide array
of fluids. The Single Tooth Anesthesia (STA(TM))
computer-controlled local anesthesia delivery system which uses
this technology provides dentists with audible and visual signals
as to in-tissue pressure. Milestone's existing painless injection
systems are currently sold in 25 countries. For more information on
these and other innovative Milestone products, please visit the
Company's web site found at http://www.milesci.com/. Safe Harbor
Statement This press release contains forward-looking statements
regarding the timing and financial impact of the Milestone's
ability to implement its business plan, expected revenues and
future success. These statements involve a number of risks and
uncertainties and are based on assumptions involving judgments with
respect to future economic, competitive and market conditions and
future business decisions, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
on Form 10-KSB for the year ended December 31, 2006. The forward
looking-statements in this press release are based upon
management's reasonable belief as of the date hereof. Milestone
undertakes no obligation to revise or update publicly any
forward-looking statements for any reason. FOR MORE INFORMATION,
PLEASE CONTACT: Elite Financial Communications Group, LLC Dodi
Handy, President and CEO, or Daniel Conway, Chief Strategist
407-585-1080 or via email at DATASOURCE: Milestone Scientific, Inc.
CONTACT: Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategist, +1-407-585-1080, , both of Elite Financial
Communications Group, LLC for Milestone Scientific, Inc. Web site:
http://www.milesci.com/
Copyright